Guardant Health
258 hedge funds and large institutions have $2.3B invested in Guardant Health in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 87 increasing their positions, 85 reducing their positions, and 79 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more call options, than puts
Call options by funds: $63.3M | Put options by funds: $42.2M
2% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 85
0.63% more ownership
Funds ownership: 93.19% → 93.82% (+0.63%)
13% less funds holding
Funds holding: 295 → 258 (-37)
23% less capital invested
Capital invested by funds: $2.99B → $2.3B (-$688M)
44% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
+$109M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$59.2M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
+$36.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.6M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$76.7M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$62.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$47.7M |
| 4 |
ClearBridge Investments
New York
|
-$39.7M |
| 5 |
Morgan Stanley
New York
|
-$29.1M |
GH Hedge Fund Activity: Q1 2024 in Review
258 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2024, worth a combined $2.3B — down 23% from $2.99B a quarter earlier.
Sellers outnumbered buyers: 79 funds closed out of GH and 44 opened new positions — a net loss of 35 holders — while 85 trimmed existing stakes and 87 added.
The largest buyer was Cadian Capital Management, adding an estimated $109M. The largest seller was AllianceBernstein, cutting an estimated $76.7M.
- 258 institutional investors held Guardant Health (GH) as of Q1 2024, down from 295 in Q4 2023.
- Funds reported $2.3B of Guardant Health stock for Q1 2024, down 23% quarter-over-quarter.
- 44 funds opened new Guardant Health positions in Q1 2024 and 79 closed out, a net change of -35 holders.
- The largest Guardant Health buyer in Q1 2024 was Cadian Capital Management, an estimated $109M added.
- The largest Guardant Health seller in Q1 2024 was AllianceBernstein, an estimated $76.7M sold.
Based on aggregated 13F filings for Q1 2024.